Contagious Agalactia In Sheep And Goats: Prevention Guide

Contagious agalactia represents a significant health challenge for sheep and goat producers worldwide, primarily driven by Mycoplasma agalactiae and related species. This bacterial infection targets multiple systems, leading to reduced productivity and economic losses through diminished milk yield, lameness, and occasional mortality.

The Pathogens Behind the Disease

At the core of contagious agalactia is Mycoplasma agalactiae, a wall-less bacterium that thrives in the mucous membranes of small ruminants. In sheep, this species dominates, while goats face threats from additional mycoplasmas such as Mycoplasma mycoides subsp. capri, Mycoplasma capricolum subsp. capricolum, and Mycoplasma putrefaciens. These organisms exhibit genetic plasticity, enabling them to evade immune responses and persist in hosts, complicating eradication efforts.

Mycoplasmas lack a cell wall, making them resistant to certain antibiotics like beta-lactams, and their small genome allows rapid adaptation to host environments. Infected animals often become chronic carriers, shedding the bacteria asymptomatically via milk, nasal secretions, or ear canals, particularly in goats where auricular carriage is prevalent.

How the Infection Spreads in Herds

Transmission occurs through multiple routes, amplifying the disease’s contagious nature. Primary spread in young animals happens via suckling contaminated colostrum or milk from infected dams. In adult flocks, milking equipment serves as a key vector, transferring bacteria between teats during routine procedures.

Aerosol droplets from respiratory secretions, direct nose-to-nose contact, and contaminated environmental surfaces like feeders, water troughs, and bedding further facilitate dissemination. Venereal transmission is suspected in rams and bucks, with bacteria detected in semen. Introducing carrier animals from external sources, such as during transhumance or market sales, often sparks outbreaks, leading to high morbidity in naive herds.

• Oronasal route: Nasal and ocular discharges from sick animals.
• Mammary route: Milking parlors and handler contact.
• Vertical transmission: Colostrum and milk to offspring.
• Indirect: Fomites and shared housing.

Recognizing Clinical Manifestations

The disease presents variably, rarely affecting all systems in one animal. Incubation typically lasts 1-3 weeks, followed by acute or subacute phases. Systemic signs include fever (up to 106°F), lethargy, anorexia, and weight loss.

Mammary Gland Involvement

Mastitis is the hallmark, starting as interstitial inflammation with a hot, swollen udder. Milk production plummets suddenly, becoming watery, yellowish, clotted, or purulent, often blocking teats. Chronic cases lead to glandular atrophy, fibrosis, and permanent agalactia, with udder shrinkage and enlarged retromammary lymph nodes.

Joint and Locomotion Issues

Arthritis affects kids, lambs, ewes, and does, causing unilateral or bilateral lameness. Swollen, hot joints—especially carpal and tarsal—prompt animals to recumbency. Erosions, fibrin deposits, and ankylosis occur pathologically, impairing mobility in meat breeds.

Ocular and Respiratory Effects

Keratoconjunctivitis begins with serous discharge, progressing to corneal opacity, purulent exudates, ulceration, and blindness, sometimes exacerbated by co-infections like Moraxella ovis. Pneumonia, more common in kids, features respiratory distress.

Reproductive and Systemic Complications

Abortions stem from bacteremia, alongside orchitis in males. Septicemia can prove fatal in youngstock, though mortality is generally low. Recrudescence follows stress, underscoring carrier status.

Pathological Changes in Affected Tissues

Grossly, mastitic udders appear atrophic with abscesses. Microscopically, fibrosis replaces acini, reducing secretory tissue. Joints show edema, fibrin synovitis, and cartilage erosion. Ocular lesions feature leukocyte infiltration and purulent infiltrates. Chronic infections may involve subtle changes in lungs, nerves, and other organs.

Differential diagnoses include staphylococcal/ streptococcal mastitis, lentivirus-induced arthritis, and chlamydial pinkeye. Laboratory confirmation is essential.

Diagnostic Approaches

Diagnosis relies on clinical suspicion plus lab tests. Culture from milk, joint fluid, conjunctival swabs, or ear cerumen isolates mycoplasmas, though fastidious growth requires special media. PCR detects DNA rapidly with high sensitivity. Serology via ELISA identifies antibodies, but carriers may test negative.

Histopathology reveals characteristic lesions, aiding confirmation. In outbreaks, testing milk bulk tanks screens herds efficiently.

Treatment Strategies and Limitations

Antimicrobials like tetracyclines, macrolides (tylosin, erythromycin), and fluoroquinolones target mycoplasmas, administered systemically or intramammary. Early intervention curbs acute cases, but chronic infections persist due to biofilms and intracellular hiding.

Treatment during lactation risks residues; cull severely affected animals. Supportive care includes anti-inflammatories for joints and eyes.

Prevention and Control Measures

Vaccines exist but show variable efficacy, unsuitable during outbreaks. Core strategies emphasize biosecurity:

• Quarantine new introductions; test ear swabs in goats.
• Disinfect milking equipment rigorously.
• Segregate kids from dams post-colostrum.
• Avoid overcrowding and stress.
• Slaughter test-and-remove positives in high-value herds.

In endemic areas, culling carriers and all-in-all-out systems help. Regulatory reporting is mandatory in regions like Scotland.

Economic and Welfare Implications

Contagious agalactia slashes milk yields by 50-100%, devalues meat animals via lameness, and incurs vet costs. Welfare suffers from pain, blindness, and mobility loss. Global enzootic status demands vigilant management.

Frequently Asked Questions (FAQs)

What causes contagious agalactia?

Primarily Mycoplasma agalactiae in sheep and goats, with other mycoplasmas in goats.

Is it fatal?

Rarely; most cases are subacute, but septicemia affects neonates.

How do I prevent spread in my herd?

Implement biosecurity, test carriers, and sanitize equipment.

Can vaccines fully protect?

Efficacy varies; use preventively, not in active outbreaks.

Is it notifiable?

Yes, in many countries—report suspicions immediately.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb